Clinical Trial Update: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 [Phase 2]

View source ↗

Summary

Phase 2 FLUOPANC trial evaluating fluorescence-guided surgery for pancreatic adenocarcinoma and cholangiocarcinoma using the fluorescent agent cRGD-ZW800-1 has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• cRGD-ZW800-1

Snippet

Sponsor: Leiden University Medical Center | Conditions: Pancreas Adenocarcinoma, Cholangiocarcinoma | Phase 2 | Status: COMPLETED